The Petri Dish: Biogen's CEO search stalls again; A setback for Verve
The FDA ordered a pause to the development Verve Therapeutics' base-editing gene therapy.
LocalNews
0
36
The FDA ordered a pause to the development Verve Therapeutics' base-editing gene therapy.
